Treatment of COVID-19 Complications

The majority of people who have COVID-19 recover entirely within a few weeks. However, some people continue to experience symptoms after their initial recovery and the most common symptoms and causes include:

• Fatigue • Shortness of breath • Cough • Chest pain • Muscle pain • Fever • Sore throat • Loss of taste or smell • Damage to the lungs leading to long-term breathing problems.

The SARS-CoV-2 virus primarily affects the respiratory system and can cause life-threatening pneumonia. Studies show the disease attacks the respiratory system and affects multiple organs with blood clots and inflammation.

The COVID-19 pandemic has adversely impacted global public health and the international economy and millions of people are suffering from COVID-19 complications.
For this reason, there is an urgent need for effective therapy for the treatment of these symptoms. To date, numerous clinical trials have been filed in the USA to examine the safety and efficacy of mesenchymal stem cells and their exosomes for treating COVID-19 patients.

At PRMEDICA, the medical team has developed protocols to treat patients for the effects of COVID-19 complications. Several clinical studies have been conducted on SARS-CoV-2 positive patients using mesenchymal stem cells and MSC-derived exosomes, with promising results link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224671/.

Mesenchymal stem cells can modulate the proliferation, activation, and effector function of all immune cells that play an essential role in the pathogenesis of acute and chronic inflammatory lung diseases. PRMEDICA has developed protocols using cord tissue-derived mesenchymal stem cells and optimal-purity, isolated MSC-derived exosomes to successfully treat respiratory system complications for patients recovering from COVID-19.

PRMEDICA protocol for the treatment of Respiratory System Complications.

• 1. The patient requires the following studies:
  • a. Bloodwork panel with cancer markers
  • b. Chest X-Ray or CT scan
  • c. General Spirometry studies
• 2. After the patient is diagnosed, the attending doctor determines the number of stem cells and exosomes to be applied, depending on the patient´s weight and the severity of the condition.

PROCEDURE:

• 2 x Simple nebulization (saline solution) (One before stem cell/exosome nebulization and one after)
• 3 x IV Ozone (apply the same day as the nebulization)
• 1 x nebulization with 10 million stem cells and 3 ml exosomes
• 1 x IV infusion of up to 200 million stem cells and 10 ml exosomes.
• 3 x Hyperbaric Oxygen therapy.

Contact PRMEDICA for further information about Nebulized and Intravenous Stem Cell Therapy for the treatment of Lung Disease and other COVID-19 related complications.